The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
Paper No. 51
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte RUEY S. LIOU, EDWARD M. ROSEN, CECILY ROU-YUN SUN,
BILL NAI-CHAU, SEK C. FUNG, TSE-WEN CHANG
and NANCY T. CHANG
__________
Appeal No. 1997-3274
Application No. 08/015,248
__________
ON BRIEF
__________
Before WINTERS, WILLIAM F. SMITH and SCHEINER, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This is an appeal under 35 U.S.C. ' 134 from the final rejection of claims 12, 27
and 30, the only claims remaining in the application. The claims read as follows:
12. A chimeric immunoglobulin comprising an antigen binding region derived
from the murine immunoglobulin BAT123 or an immunoglobulin which specifically binds
to the same epitope as BAT123 and a human constant region.
27. A chimeric monoclonal immunoglobulin having a variable region of rodent
origin and a constant region of human origin which binds to an epitope within a peptide
including amino acid residue numbers 308 to 322 of gp120 of HIV-1B, as designated by
the numbering system set forth in Human Retroviruses and AIDS 1990, Loa Alamos
National Laboratory (Eds. Myers, G. et al.).
30. A chimeric monoclonal immunoglobulin having a variable region of rodent
origin and a constant region of human origin which binds to the amino acid sequence
RIQRGPGRAFVTIGK.
Page: 1 2 3 4 5 6 7 8 Next
Last modified: November 3, 2007